secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevation Oncology, Inc. (—)
CIK:        0001783032
Form:       8-K
Filed at:   2023-07-13T23:59:59+00:00
Accession:  0001558370-23-011852
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Elevation Oncology appoints Joseph Ferra as permanent CEO and Tammy Furlong as CFO
--------------------------------------------------------------------------------

- Joseph J. Ferra Jr. appointed President & CEO effective July 12, 2023; he steps down as CFO.
- Tammy Furlong, previously VP of Finance, appointed CFO effective July 12, 2023.
- Ferra's base salary increased to $600,000, target bonus 50%, and options for 35,000 shares.
- Furlong's base salary increased to $430,000, target bonus 40%, and options for 53,433 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783032/000155837023011852/0001558370-23-011852-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783032/000155837023011852/elev-20230712x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011852

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer